Greenberg Traurig has garnered attention with its recent addition of Robert Ward as a shareholder in its life sciences and medical technology practice, based in San Diego. The firm announced Tuesday that Ward will be a pivotal figure within the team, focusing on intellectual property-related matters, especially for companies in the medical device and digital health sectors.
Ward brings substantial expertise to the table, particularly in developing global patent portfolios for both established and fledgling companies, many of which incorporate artificial intelligence and machine learning technologies. His portfolio also includes advising on IP licensing, development, consulting, and manufacturing agreements, as well as navigating the complexities of acquisitions and spinouts.
Prior to joining Greenberg Traurig, Ward served at Eversheds Sutherland, where he was instrumental in advising technology companies alongside venture capital firms in navigating the intricate landscapes of intellectual property. Given his extensive background, his addition to Greenberg Traurig’s team is expected to significantly bolster the firm’s capabilities in addressing the nuanced challenges faced by life sciences companies today.
For more detailed information, you can read the full announcement here.